Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing | News
Search Refinements

Manufacturing News

View news from other Pharmaceutical sectors:
136-150 of 2230 results
Merck to expand Carlsbad viral and gene therapy plant in California
Merck has announced an expansion of its Carlsbad, California facility to meet growing demand for viral and gene therapy products.
Production & Manufacturing > Manufacturing > News
EMD Serono expands biopharmaceutical R&D facility in Billerica, Massachusetts
EMD Serono, the biopharmaceutical business of Merck KGaA, in North America, announced a $12m investment for the expansion of its R&D facility in Billerica, Massachusetts.
Production & Manufacturing > Manufacturing > News
Alnylam breaks ground on new manufacturing Facility in Norton, Massachusetts
Alnylam Pharmaceuticals has break ground on a biopharmaceutical manufacturing facility in Norton, Massachusetts.
Production & Manufacturing > Manufacturing > News
AbbVie agrees to buy Stemcentrx for $5.8bn
By PBR Staff Writer
AbbVie has agreed to acquire cancer drug startup Stemcentrx in a transaction valued at about $5.8bn.
Production & Manufacturing > Manufacturing > News
Sanofi offers to buy Medivation for $9.3bn
By PBR Staff Writer
French drug maker Sanofi has made a nonbinding offer to acquire the American biopharmaceutical firm Medivation for about $9.3bn.
Production & Manufacturing > Manufacturing > News
Allergan breaks ground on $200m Waco facility expansion in Texas
By PBR Staff Writer
Allergan has broken ground on a $200m expansion of its Waco facility in Texas, US, which will increase its manufacturing capacity by over 50%.
Production & Manufacturing > Manufacturing > News
GSK opens respiratory manufacturing facility in Ware, UK
GSK has opened a £56m manufacturing facility, creating 150 new jobs in the UK, in response to demand for GSK’s portfolio of respiratory medicines delivered by the innovative Ellipta inhaler.
Production & Manufacturing > Manufacturing > News
Mylan announces US launch of Generic Lopressor Tablets 37.5 mg and 75 mg
Mylan announced the U.S. launch of Metoprolol Tartrate Tablets USP, 37.5 mg and 75 mg, which is the generic version of Novartis' Lopressor Tablets.
Production & Manufacturing > Manufacturing > News
Recipharm acquires majority stake in Nitin Lifesciences
Recipharm AB has completed the acquisition of a majority stake in Nitin Lifesciences Limited (“Nitin”), an Indian sterile injectables CMO, currently owned by the Sobti family.
Production & Manufacturing > Manufacturing > News
PharmaCyte's encapsulation facility for pancreatic cancer therapy deemed suitable by Thai FDA
PharmaCyte Biotech reported that the encapsulation facility located in Bangkok, Thailand, that will be used to encapsulate the live cells used for PharmaCyte’s pancreatic cancer therapy has recently been inspected by the Food and Drug Administration of Thailand (Thai FDA).
Production & Manufacturing > Manufacturing > News
Pfizer terminates $160bn merger with Allergan
By PBR Staff Writer
Pfizer has terminated its $160bn merger with Allergan, after the US Government took new steps to bring an end to tax inversion agreements.
Production & Manufacturing > Manufacturing > News
Gilead Sciences to acquire Nimbus Apollo in $1.2bn deal
By PBR Staff Writer
Gilead Sciences has agreed to acquire Nimbus Therapeutics' subsidiary Nimbus Apollo and its Acetyl-CoA Carboxylase (ACC) inhibitor program in a transaction valued at up to $1.2bn.
Production & Manufacturing > Manufacturing > News
FTC seeks additional data on $160bn Pfizer-Allergan merger
By PBR Staff Writer
The US Federal Trade Commission (FTC) has requested additional information from Pfizer and Allergan on their proposed $160bn merger deal.
Production & Manufacturing > Manufacturing > News
Ariad Pharmaceuticals to cut 25% of headquarter positions
ARIAD Pharmaceuticals is reducing approximately 25% of its headquarter positions.
Production & Manufacturing > Manufacturing > News
Shire wins patent trial against Allergan in Lialda patent case in US
By PBR Staff Writer
A US district court ruled in favor of Shire Plc, preventing Allergan from selling generic versions of the ulcerative colitis drug, Lialda, until 2020.
Production & Manufacturing > Manufacturing > News
136-150 of 2230 results